Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

NCT07034859 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07034859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07034859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
May 20, 2024
Completion date
December 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mri, pituitary adenoma, rct